← The SEC Ephemeris: the whole map
Green Cross Corporation immune globulin
In the graph: all 1 documents (2 pages).
- Ticker
- Green Cross Corporation
- Product
- immune globulin
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- February 25, 2022
From FDA letters and SEC filings. Not investment or medical advice.